Drug combination and use for treating tumors
US11986477B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2023 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Nov 6, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.